Aspirin Reduces COVID-19 Mortality: Investigator's Insights
Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.
Principal investigator Jonathan Chow, MD, assistant professor of anesthesiology at the University of Maryland School of Medicine, highlights study results and discusses possible mechanisms.
For details of Dr Chow's study, see: Low-dose Aspirin Reduces Risk of COVID-19 Mortality in Hospitalized Patients.
Recent Videos
Related Content
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025Article
The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.
